You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Monoclonal antibodies (mAb)

Showing 1 - 25 of 8,220
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Medicare Anti-Aß mAb Coverage With Evidence Development Study

Recruiting
  • Mild Alzheimer's Disease
  • Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
  • Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
  • Baltimore, Maryland
    Centers for Medicare and Medicaid Services
Sep 21, 2023

Solid Tumor, Adult Trial in United States (FT538, Cyclophosphamide, Fludarabine)

Recruiting
  • Solid Tumor, Adult
  • Hackensack, New Jersey
  • +3 more
Apr 14, 2022

Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in

Not yet recruiting
  • Non-Hodgkin Lymphoma, B-cell
  • "novel" MAB (alone or in combination)
  • Viagrande, Catania, Italy
  • +57 more
Aug 18, 2023

Ebola Virus Disease Trial in N'Zerekore (ansuvimab, Ervebo)

Not yet recruiting
  • Ebola Virus Disease
  • N'Zerekore, Guinea
    Centre de Traitement Ebola de N'Zerekore
Oct 14, 2021

HIV Trial in Worldwide (VRC01, VRC01LS, VRC07-523LS)

Completed
Has Results
  • HIV Infections
  • VRC01
  • +2 more
  • Los Angeles, California
  • +13 more
Dec 19, 2022

Pyoderma, Pyoderma Gangrenosum, Pyoderma Vegetans Trial in Minsk, Riga (Monoclonal antibody (Mab) sB24M)

Active, not recruiting
  • Pyoderma
  • +3 more
  • Monoclonal antibody (Mab) sB24M
  • Minsk, Belarus
  • +1 more
Jul 8, 2022

NSCLC Trial in Shanghai (Capsulized Fecal Microbiota Transplant, Anti-programmed cell death protein 1/programmed death-ligand 1

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Capsulized Fecal Microbiota Transplant
  • +2 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Aug 12, 2021

Alzheimer Trial (Lecanemab)

Not yet recruiting
  • Alzheimer Disease
  • (no location specified)
Jun 22, 2023

Hepatitis b Virus Trial in New York (HepB mAb19, Sterile Saline)

Not yet recruiting
  • Hepatitis b Virus
  • HepB mAb19
  • Sterile Saline
  • New York, New York
  • +1 more
May 12, 2023

Migraine, Migraine With Aura, Migraine Without Aura Trial (Erenumab, Fremanezumab, Galcanezumab)

Recruiting
  • Migraine
  • +4 more
  • Innsbruck, Tirol, Austria
  • +2 more
Oct 19, 2022

HIV Trial in South Africa (VRC01.23LS, PGT121.414.LS, PGDM1400LS)

Not yet recruiting
  • HIV Infections
  • VRC01.23LS
  • +2 more
  • Cape Town, Western Cape, South Africa
  • +7 more
Jul 24, 2023

Idiopathic Pulmonary Fibrosis Trial (CHF10067 starting dose, CHF10067 intermediate dose, CHF10067 high dose)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • CHF10067 starting dose
  • +3 more
  • (no location specified)
Aug 22, 2022

Rabies Virus Infection Trial in Kunming (Natural full human mAb CBB 1 injection, Rabies Human Immunoglobulin (HRIG), Natural

Not yet recruiting
  • Rabies Virus Infection
  • Natural full human monoclonal antibody CBB 1 injection
  • +3 more
  • Kunming, Yunnan, China
    The First Affiliated Hospital of Yunnan University of Traditiona
Apr 14, 2023

Allergic Rhinitis, Conjunctivitis Trial (REGN5713, REGN5714, REGN5715)

Not yet recruiting
  • Allergic Rhinitis
  • Conjunctivitis
  • (no location specified)
Jun 20, 2022

Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)

Recruiting
  • Neuroblastoma
  • Ganglioneuroblastoma
  • monoclonal antibodies GD2
  • Moscow, Russian Federation
    Research Institute of Pediatric Hematology, Oncology and Immunol
Oct 4, 2023

Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer Trial in Huntersville (FT536, Cyclophosphamide, Fludarabine)

Recruiting
  • Non Small Cell Lung Cancer
  • +6 more
  • Scottsdale, Arizona
  • +4 more
Dec 27, 2022

Idiopathic Multicentric Castleman's Disease Trial in Beijing, Chengdu (Recombinant Humanized Anti-interleukin-6 Receptor

Recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg
  • +2 more
  • Beijing, China
  • +2 more
Apr 26, 2022

Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment

Recruiting
  • COVID-19 Convalescent Plasma Treatment
    • Strasbourg, France
      Service des Maladies Infectieuses et Tropicales - CHU de Strasbo
    Jun 15, 2023

    Rheumatoid Arthritis Trial in China (IL-6R Monoclonal Antibody Injection 4mg/kg, IL-6R Monoclonal Antibody Injection 6mg/kg,

    Completed
    • Rheumatoid Arthritis
    • IL-6R Monoclonal Antibody Injection 4mg/kg
    • +3 more
    • Baoding, China
    • +4 more
    Feb 24, 2022

    Clostridium Infection Trial in Paris (Collection of peripheral blood mononuclear cells)

    Completed
    • Clostridium Infection
    • Collection of peripheral blood mononuclear cells
    • Paris, France
      Maladies infectieuses et tropicales, Hôpital Pitié-Salpêtrière
    Oct 3, 2022

    Hemorrhagic Fever, Ebola Trial in Congo, The Democratic Republic of the, Sierra Leone (Ansuvimab)

    Available
    • Hemorrhagic Fever, Ebola
    • Mbandaka, Equateur, Congo, The Democratic Republic of the
    • +3 more
    May 3, 2022

    Solid Tumor, Adult Trial in Minneapolis, Hackensack, Houston (FT516, Avelumab, Cyclophosphamide)

    Completed
    • Solid Tumor, Adult
    • Minneapolis, Minnesota
    • +2 more
    Jan 27, 2023

    Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)

    Not yet recruiting
    • Monoclonal Gammopathy of Uncertain Significance
    • Zanubrutinib Oral Product
    • Utrecht, Netherlands
      University Medical Center Utrecht
    Jul 6, 2023

    Advanced Lung Carcinoma, Advanced Malignant Solid Tumor, Malignant Adrenal Gland Tumor Trial in Houston (Anti-CTLA4 Monoclonal

    Recruiting
    • Advanced Lung Carcinoma
    • +16 more
    • Anti-CTLA4 Monoclonal Antibody BMS-986218
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2022

    Non-Malignant Tumor Trial in Seattle (biological, drug, radiation, procedure)

    Recruiting
    • Non-Malignant Neoplasm
    • Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
    • +7 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 29, 2022